Quick Answer
Sotera Health Co reported Operating Income Loss of $297.63 million for the year ending 2024.
- Sotera Health Co showed an increase of +7.6% in Operating Income Loss from 2023 to 2024.
- This data is from Sotera Health Co's annual report (Form 10-K), filed with the SEC on February 27, 2025.
- XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $44.87 million | Q2 2020: $61.74 million | Q3 2020: $47.03 million | Q1 2021: $46.36 million | Q2 2021: $78.27 million | Q3 2021: $65.67 million | Q1 2022: $53.49 million | Q2 2022: $71.50 million | Q3 2022: $63.20 million | Q1 2023: $33.37 million | Q2 2023: $63.20 million | Q3 2023: $76.10 million | Q1 2024: $53.17 million | Q2 2024: $76.80 million | Q3 2024: $80.51 million.
- Over the full 6 years of available data (2019 to 2024), Sotera Health Co's Operating Income Loss has grown by 62.1%.
- Historical annual values: Fiscal year 2024: $297.63 million | Fiscal year 2023: $276.69 million | Fiscal year 2022: $248.35 million | Fiscal year 2021: $256.73 million | Fiscal year 2020: $206.02 million | Fiscal year 2019: $183.60 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: